Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility

mBio(2023)10.1128/mbio.03168-22Source: DataRank Database

Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility is a research paper published in mBio (2023). On theSindex it has a DataRank of 0. It has been cited 49 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access49 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (39)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Vijay Soni ORCID,Kyu Y. Rhee ORCID,John D. Helmann ORCID,Yesha Patel ORCID

Live enrichment

PubMed:36779708 PMC:PMC10128067

HHS | National Institutes of Health

Grant: R35GM122461

HHS | National Institutes of Health

Grant: U19AI162584

HHS | National Institutes of Health

Grant: R25140472

National Institutes of Health

Grant: 1U19AI162584-01

Metabolic determinants of Mtb virulence, vulnerability and variation

National Institutes of Health

Grant: 5R35GM122461-07

Bacillus subtilis stress responses

goldLicense: cc-by

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.03168-22?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.03168-22

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10128067/pdf/mbio.03168-22.pdf

repositoryhttps://doaj.org/article/a1fd8822e8e2421c9b990e094168d469

Unpaywallhttps://doi.org/10.1128/mbio.03168-22

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Mycobacterium tuberculosisbeta-LactamsCefuroximeRifampinDNA-Directed RNA PolymerasesAcetylglucosaminePeptidoglycanBacterial ProteinsUridine DiphosphateAntitubercular AgentsMicrobial Sensitivity TestsDrug Resistance, BacterialMutation

Keywords

Mycobacterium tuberculosisBacillus subtilisRNA polymerasesAntibiotic ResistancepeptidoglycanMetabolomicsrifampicinΒ-lactamsAntibiotic SynergyCefuroximeAntitubercular AgentsDNA-Directed RNA PolymerasesMicrobial Sensitivity Testsbeta-LactamsMicrobiologyQR1-502Uridine DiphosphateAcetylglucosamineBacterial ProteinsDrug Resistance, BacterialMutationRifampinResearch Article

Sustainable Development Goals

SDG 3: 3. Good health